Bispecific antibody targeting of lipid nanoparticles
Angelo Amabile(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Tisch Hospital), Zhe Yu(Nanoparticle BioChem (United States)), Gürkan Mollaoglu(New York University), Chiara Falcomatà(Icahn School of Medicine at Mount Sinai), Abraham J. P. Teunissen(DMS Imaging (France)), Judit Morlà‐Folch(DMS Imaging (France)), Pedro Silva(Universidade do Porto), Moah Sohn(Precision for Medicine (United States)), Adam Marks(Icahn School of Medicine at Mount Sinai), Yizhou Dong(Precision for Medicine (United States)), Joshua Brody(Icahn School of Medicine at Mount Sinai)
Cited by 10
Related Papers
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
|Immunity|2016|1.2k
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|607
The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments
|Nature Communications|2021|335
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment
|Immunity|2018|216
A Narrative Review of Motor Competence in Children and Adolescents: What We Know and What We Need to Find Out
|International Journal of Environmental Research and Public Health|2020|197